rhNRG-1 and rhErbB3-f were recognized as "Shanghai high-tech achievement transformation projects"
2006-01-11
In December 26, 2005, Zensun’s two proprietary research projects - recombinant human Neuregulin-1(rhNRG-1) (project number: 20050522) and recombinant human ErbB3 fragment (rhErbB3-f) immunization (project number: 20050523), were officially recognized as "Shanghai high-tech achievement transformation project "and obtained " Shanghai high-tech achievement transformation project "certificate.
更多动态
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to
